S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 20.55 SEK -0.48% Market Closed
Market Cap: 1.1B SEK

SynAct Pharma AB
Investor Relations

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Show more
Loading
SYNACT
OMX Stockholm 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jeppe Ovli Ovlesen EE, MBA
CEO & Director
No Bio Available
Mr. Bjorn Westberg
Chief Financial Officer
No Bio Available
Dr. Thomas Boesen Ph.D.
Chief Operating Officer
No Bio Available
Mr. James Knight M.B.A.
Chief Business Officer
No Bio Available
Ms. Kristen Harting M.D.
Chief Medical Officer
No Bio Available

Contacts

Address
SKANE
Lund
Scheelevagen 2
Contacts